Cargando…

Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin

BACKGROUND: The aim of this study was to investigate the efficacy and safety of vildagliptin as an add-on therapy for patients with type 2 diabetes mellitus inadequately controlled with basal insulin. METHODS: Twenty-four patients treated with basal insulin and oral anti-diabetes drugs were randomly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Daisuke, Kanazawa, Akio, Shigihara, Nayumi, Sato, Fumihiko, Uchida, Toyoyoshi, Sato, Junko, Goto, Hiromasa, Miyatsuka, Takeshi, Ikeda, Fuki, Ogihara, Takeshi, Ohmura, Chie, Watada, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289138/ https://www.ncbi.nlm.nih.gov/pubmed/28179966 http://dx.doi.org/10.14740/jocmr2874w

Ejemplares similares

Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trial*
por: Sato, Junko, et al.
Publicado: (2015)

Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
por: Kudo‐Fujimaki, Kyoko, et al.
Publicado: (2013)

Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
por: Tosaka, Yuka, et al.
Publicado: (2015)

One year follow-up after a randomized controlled trial of a 130 g/day low-carbohydrate diet in patients with type 2 diabetes mellitus and poor glycemic control
por: Sato, Junko, et al.
Publicado: (2017)

Everolimus Directly Suppresses Insulin Secretion Independently of Cell Growth Inhibition
por: Suzuki, Luka, et al.
Publicado: (2018)

Postprandial Plasma Glucagon Kinetics in Type 2 Diabetes Mellitus: Comparison of Immunoassay and Mass Spectrometry
por: Katahira, Takehiro, et al.
Publicado: (2018)

Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study
por: Sato, Junko, et al.
Publicado: (2017)

A Pilot Study of Intervention With a Mobile Application Visualizing the Macronutrient Content for Type 2 Diabetes at a Japanese Center
por: Tsunemi, Asako, et al.
Publicado: (2021)

Combination of the Framingham Risk Score and Carotid Intima-Media Thickness Improves the Prediction of Cardiovascular Events in Patients With Type 2 Diabetes
por: Yoshida, Michiko, et al.
Publicado: (2012)

Prevalence of Amiodarone-Induced Thyrotoxicosis and Associated Risk Factors in Japanese Patients
por: Uchida, Toyoyoshi, et al.
Publicado: (2014)

Enhanced Expression of the Key Mitosis Regulator Cyclin B1 Is Mediated by PDZ-Binding Kinase in Islets of Pregnant Mice
por: Uesato, Tadayoshi, et al.
Publicado: (2018)

Impact of Oxidative Stress and Peroxisome Proliferator–Activated Receptor γ Coactivator-1α in Hepatic Insulin Resistance
por: Kumashiro, Naoki, et al.
Publicado: (2008)

Defective autophagy in vascular smooth muscle cells enhances the healing of abdominal aortic aneurysm
por: Mochida, Akihiro, et al.
Publicado: (2021)

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
por: Li, Chun-Jun, et al.
Publicado: (2014)

Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
por: Tang, Yun-Zhao, et al.
Publicado: (2015)

Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study
por: Kanazawa, Akio, et al.
Publicado: (2021)

Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study
por: Ogihara, Takeshi, et al.
Publicado: (2017)

Diabetic ketoacidosis due to a sensor defect of FreeStyle Libre: A case report
por: Kogai, Toshiki, et al.
Publicado: (2023)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

Effect of Plasma Exchange in Thyroid Storm With Consideration of Its Distribution Into the Extravascular Space
por: Shinohara, Mai, et al.
Publicado: (2020)

Clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes: A retrospective study
por: Tamaki, Shoko, et al.
Publicado: (2019)

Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
por: Odawara, Masato, et al.
Publicado: (2014)

Cellular Autophagy in α Cells Plays a Role in the Maintenance of Islet Architecture
por: Himuro, Miwa, et al.
Publicado: (2019)

Identification and comparison of insulin pharmacokinetics injected with a new 4‐mm needle vs 6‐ and 8‐mm needles accounting for endogenous insulin and C‐peptide secretion kinetics in non‐diabetic adult males
por: Hirose, Takahisa, et al.
Publicado: (2013)

Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
por: Li, Feng-fei, et al.
Publicado: (2017)

Continuous glucose monitoring system: Is it really accurate, safe and clinically useful?
por: Sato, Junko, et al.
Publicado: (2012)

Comparison of effects of cilnidipine and azelnidipine on blood pressure, heart rate and albuminuria in type 2 diabetics with hypertension: A pilot study
por: Abe, Hiroko, et al.
Publicado: (2012)

Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients
por: Cakirca, Mustafa, et al.
Publicado: (2014)

Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
por: Lukashevich, V, et al.
Publicado: (2014)

Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
por: Al Omari, Mousa, et al.
Publicado: (2016)

Chronological Analysis With Fluorescent Timer Reveals Unique Features of Newly Generated β-Cells
por: Miyatsuka, Takeshi, et al.
Publicado: (2014)

STAT3 suppression and β-cell ablation enhance α-to-β reprogramming mediated by Pdx1
por: Wakabayashi, Yuka, et al.
Publicado: (2022)

Combination treatment of db/db mice with exendin‐4 and gastrin preserves β‐cell mass by stimulating β‐cell growth and differentiation
por: Tamaki, Motoyuki, et al.
Publicado: (2010)

Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases
por: Berardis, Domenico De, et al.
Publicado: (2021)

Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece
por: Kousoulakou, Hara, et al.
Publicado: (2017)

Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes
por: Miyagawa, Katsutoshi, et al.
Publicado: (2013)

Vildagliptin-induced acute lung injury: a case report
por: Ohara, Nobumasa, et al.
Publicado: (2016)

Morningness–eveningness questionnaire score correlates with glycated hemoglobin in middle‐aged male workers with type 2 diabetes mellitus
por: Iwasaki, Masato, et al.
Publicado: (2013)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_52ok0f8idh5v4m29enl33jve5m